MX9708618A - 'beta'-ADRENERGIC AGONISTS. - Google Patents

'beta'-ADRENERGIC AGONISTS.

Info

Publication number
MX9708618A
MX9708618A MX9708618A MX9708618A MX9708618A MX 9708618 A MX9708618 A MX 9708618A MX 9708618 A MX9708618 A MX 9708618A MX 9708618 A MX9708618 A MX 9708618A MX 9708618 A MX9708618 A MX 9708618A
Authority
MX
Mexico
Prior art keywords
beta
adrenergic agonists
adrenergic
agonists
obesity
Prior art date
Application number
MX9708618A
Other languages
Spanish (es)
Inventor
Robert L Dow
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority claimed from PCT/IB1995/000342 external-priority patent/WO1996035670A1/en
Publication of MX9708618A publication Critical patent/MX9708618A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

'beta'-adrenergic agonists for the treatment of diseases/conditions such as obesity and diabetes. The compounds have formula (I) wherein R1, R2, R3, R4, R5, R6, R7, W, X, Y and Z are as defined in the specification.
MX9708618A 1995-05-10 1995-05-10 'beta'-ADRENERGIC AGONISTS. MX9708618A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1995/000342 WO1996035670A1 (en) 1995-05-10 1995-05-10 β-ADRENERGIC AGONISTS

Publications (1)

Publication Number Publication Date
MX9708618A true MX9708618A (en) 1998-02-28

Family

ID=39263360

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9708618A MX9708618A (en) 1995-05-10 1995-05-10 'beta'-ADRENERGIC AGONISTS.

Country Status (1)

Country Link
MX (1) MX9708618A (en)

Similar Documents

Publication Publication Date Title
MX9708621A (en) 'beta'-ADRENERGIC AGONISTS.
BG101112A (en) The use of heterocyclic compounds
BG103399A (en) New heterocycle-substituted benzamides and their application for the treatment of diseases
ZA954548B (en) Monoamine diamide thiol-containing metal chelating agents
NZ332762A (en) Isobutylgaba and its derivatives for the treatment of pain
GB9514473D0 (en) Chemical compounds
AP9801312A0 (en) 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide y receptor anatagonist.
NZ516599A (en) 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands
MXPA04005847A (en) 4-sulfide / sulfoxide / sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor.
NZ233735A (en) Heterocyclic substituted aminophenol derivatives
AP9701041A0 (en) Pyridylpyrrole compounds.
MX9700429A (en) Use of thiazole and thiadiazole compounds as d3 dopamine receptor ligands.
AU2672995A (en) {a}-annelated pyrrole derivatives and pharmaceutical uses thereof
CA2176935A1 (en) Indole-derived azylpiperazines as ligands for 5ht1-like receptors 5ht1b and 5ht1d
CA2192975A1 (en) Benzimidazolone Derivatives
GB9206768D0 (en) New compounds for use in the treatment of cancer
PT775118E (en) BENZIMIDAZOLE DERIVATIVES WITH DOPAMINERGIC ACTIVITY
ZA949593B (en) N-substituted azabicycloheptane derivatives their preparation and use
MY132057A (en) Quinoxalinones, a process for their preparation and their use
MY114282A (en) Anthracycline derivatives
MX9700813A (en) New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments.
GR3023427T3 (en) Heteroarylmethylbenzols aromatase inhibitors
MX9708618A (en) 'beta'-ADRENERGIC AGONISTS.
GB9420747D0 (en) 1,5 benzodiazepine derivatives
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes